期刊文献+

KRT23在胃癌组织中的表达及其临床意义 被引量:2

Expression of KRT23 in gastric cancer tissue and its clinical significance
下载PDF
导出
摘要 目的:研究胃癌组织中角蛋白23(KRT23)的表达情况及其临床意义。方法:收集4例新鲜的胃癌组织及其对应的癌旁组织,85例胃癌蜡块和与其匹配的癌旁组织,通过Western blot检测KRT23蛋白表达水平。并应用免疫组化方法检测85例胃癌组织和与其配对的癌旁组织蜡块中KRT23蛋白的表达情况,分析KRT23蛋白表达与胃癌患者临床病理特征之间的关系。采用Cox比例风险模型及Kaplan-Meier生存分析预后相关性。结果:与癌旁组织相比,胃癌组织中KRT23蛋白表达水平明显升高(P<0.001)。KRT23蛋白表达水平与TNM分期(P=0.009)、淋巴结转移(P<0.001)有关。Kaplan-Meier生存分析提示:与KRT23阴性表达相比,KRT23阳性表达患者的总生存时间显著缩短(P<0.05)。Cox回归分析提示:KRT23阳性表达(P=0.047)、淋巴结转移(P=0.01)、TNM分期高(P=0.024)是影响胃癌患者预后的独立危险因素。结论:KRT23在胃癌患者组织中高表达,可能在胃癌发病和进展过程中发挥重要作用,为胃癌诊断、治疗和预后评估提供了新的思路和靶点。 Objective:To study the expression of keratin 23 typeⅠ(KRT23)in gastric cancer tissue and its clinical significance.Methods:Four cases of fresh gastric cancer tissue and their corresponding adjacent tissue,85 cases of paraffin tissue block and their corresponding adjacent tissue were collected,and the expression level of KRT23 protein was detected by Western blot.In addition,immunohistochemical method was used to detect the expression of KRT23 protein in 85 cases of gastric cancer tissue and paracancerous tissue paraffin block,and analyze the relationship between KRT23 protein expression and clinicopathological features of gastric cancer patients.The Cox proportional hazards model and Kaplan-Meier survival were used to analyze the prognostic correlation.Results:Compared with adjacent tissues,the expression level of KRT23 in gastric cancer tissues was significantly higher(P<0.001).The expression level of KRT23 protein was related to TNM staging(P=0.009)and lymphatic metastasis(P<0.001).Kaplan-Meier survival analysis showed that compared with KRT23 negative expression,the overall survival time of patients with KRT23 positive expression was significantly shorter(P<0.05).Cox regression analysis indicated that KRT23 positive(P=0.047),lymph node metastasis(P=0.01),and high TNM stage(P=0.024)were independent risk factors affecting the prognosis of gastric cancer patients.Conclusion:KRT23 is highly expressed in the tissue of gastric cancer patients,and may play an important role in the pathogenesis and progression of gastric cancer.It provides new ideas and targets for the diagnosis,treatment and prognosis evaluation of gastric cancer.
作者 杭群 左芦根 骆杰 朱冰 刘牧林 HANG Qun;ZUO Lugen;LUO Jie;ZHU Bing;LIU Mulin(Gastrointestinal Department,the First Affiliated Hospital of Bengbu Medical College,Anhui Bengbu 233000,China)
出处 《现代肿瘤医学》 CAS 北大核心 2021年第9期1531-1534,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81700476) 蚌埠医学院科技发展基金项目(编号:BYKF1743)。
关键词 KRT23 胃癌 临床病理学特征 预后 KRT23 gastric cancer clinicopathological features prognosis
  • 相关文献

参考文献5

二级参考文献14

  • 1Muhammed Ashraf Memon,Nick Butler,Breda Memon.The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(2):65-67. 被引量:10
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 3Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 4Mun Ki Choi,Gwang Ha Kim,Do Youn Park,Geun Am Song,Dong Uk Kim,Dong Yup Ryu,Bong Eun Lee,Jae Hoon Cheong,Mong Cho.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience[J]. Surgical Endoscopy . 2013 (11)
  • 5Andrea Coratti,Mario Annecchiarico,Michele Di Marino,Edoardo Gentile,Francesco Coratti,Pier Cristoforo Giulianotti.Robot-assisted Gastrectomy for Gastric Cancer: Current Status and Technical Considerations[J].World Journal of Surgery.2013(12)
  • 6Benjamin Schmidt,Nicole Look-Hong,Ugwuji N. Maduekwe,Kevin Chang,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David W. Rattner,John T. Mullen,Sam S. Yoon.Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients[J].Annals of Surgical Oncology.2013(11)
  • 7J. Chen,Z. Tang,X. Dong,S. Gao,H. Fang,D. Wu,D. Xiang,S. Zhang.Radiofrequency ablation for liver metastasis from gastric cancer[J].European Journal of Surgical Oncology.2013(7)
  • 8J.A. Ajani,M. Buyse,M. Lichinitser,V. Gorbunova,G. Bodoky,J.Y. Douillard,S. Cascinu,V. Heinemann,R. Zaucha,A. Carrato,D. Ferry,V. Moiseyenko.Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study[J].European Journal of Cancer.2013
  • 9Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 10Lei Jiang,Ke‐Hu Yang,Quan‐Lin Guan,Peng Zhao,Yan Chen,Jin‐Hui Tian.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta‐analysis[J].J Surg Oncol.2013(8)

共引文献184

同被引文献24

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部